Investors / United States / Alta Partners
Alta Partners
Venture capital · Jackson, WY, United States · North America
Alta Partners is a healthcare venture capital firm that has raised $2.8 billion across 12 funds since its founding in 1996. Its life science portfolio has produced over 90 FDA-approved products, and its tech-enabled services companies treat hundreds of thousands of patients each year.
Invests inHealthcare & Biotech
In its own wordshealthcarelife sciencesbiotechtech-enabled servicestherapeuticsdigital health
Your fit with Alta Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsAlta Partners lists 21 checked portfolio companies on its own site and is named in 2 funding rounds, 1 of them as lead. Its most frequent entry is Series B, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (96%) and Media & Entertainment (5%). 92% of its companies are based in United States. It invests most often alongside General Catalyst, ARCH Venture Partners and Catalio Capital Management.
Counts come from funding rounds that name Alta Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Alta Partners' whole history. Rounds on record name 2 companies; its own site lists 21. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundAlta Partners does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 100% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 1 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 53th | 21 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 76th | 10% of companies confirmed by a round |
| Sector focus | 97th | 96% in its largest sector |
| Reach | 42th | 2 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| General Catalyst | 3 |
| ARCH Venture Partners | 2 |
| Catalio Capital Management | 2 |
| Longitude Capital | 2 |
| Lux Capital | 2 |
| Oak HC/FT | 2 |
| Optum Ventures | 2 |
| Questa Capital | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers21100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 96% | 15% |
| Media & Entertainment | 5% | 4% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with General Catalyst
Compare Alta Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Alta Partners| Date | Company | Stage |
|---|---|---|
| 6 Oct 2026 | Series B Led | |
| 9 Sept 2025 | Series B |
Round details for Alta Partners
Amounts, full round histories and every co-investor in Alta Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
21 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| CuraSen Therapeutics rethinks brain disease | Healthcare & Biotech | Portfolio page | ||
| The company develops cancer therapeutics | Healthcare & Biotech | Portfolio page | ||
| DispatchHealth empowers health systems to provide hospital-quality complex care in patients' homes, at scale. | Healthcare & Biotech | Portfolio page | ||
| Edgewood Oncology is a clinical-stage biotechnology company that develops a novel small molecule, multi-kinase inhibitor to target cancer | Healthcare & Biotech | Portfolio page | ||
| eGenesis develops human-compatible organs for patients with organ failure using genome engineering and transplantation | Healthcare & Biotech | Portfolio page | ||
| Free Market Health connects the people and processes of the specialty ecosystem to keep treatments on track. | Healthcare & Biotech | Portfolio page | ||
| Harbor Health provides health care services and insurance plans to individuals, families, and employers across Texas. | Healthcare & Biotech | Sept 2025Series B | Page + round | |
| Kelonia develops genetic medicine for patients using its iGPS technology | Healthcare & Biotech | Portfolio page | ||
| KymaThera develops medicines to treat cancer and other serious diseases. | Healthcare & Biotech | Oct 2026Series B | Page + round | |
| Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases. | Healthcare & Biotech | Portfolio page | ||
| Marathon Health delivers advanced primary care for organizations with onsite, nearsite, and network centers, plus virtual care nationwide. | Healthcare & Biotech | Portfolio page | ||
| MBrace Therapeutics identifies new cancer targets for their products and develops antibody drug conjugates for cancer treatment | Healthcare & Biotech | Portfolio page | ||
| PatientsLikeMe provides a platform for members to share information about their health conditions and treatments. | Healthcare & Biotech | Portfolio page | ||
| Progentos Therapeutics is developing a new approach to treating multiple sclerosis that stimulates the body's natural repair mechanisms. | Healthcare & Biotech | Portfolio page | ||
| Qihan Biotech uses multiplexable genome editing and transplantation immunology to create therapies for medical conditions such as cancer and organ failure | Healthcare & Biotech | Portfolio page | ||
| The company uses cookies to analyze website traffic and optimize user experience. | Media & EntertainmentHealthcare & Biotech | Portfolio page | ||
| Transcarent provides a platform that brings together medical, pharmacy, and point solutions into one experience for health and care | Healthcare & Biotech | Portfolio page | ||
| The company is working to advance clinical studies of oral dabogratinib for skeletal dysplasia and urologic cancers. | Healthcare & Biotech | Portfolio page | ||
| The company provides management services to physician-owned practices specializing in musculoskeletal care. | Healthcare & Biotech | Portfolio page | ||
| Variant Bio is developing life-saving therapies by studying the genes of people with exceptional health-related traits. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- altapartners.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 9 Sept 2025
- Companies checked
- 21
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Alta Partners' profile as data
Pull Alta Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/altapartners.com
# also
GET /v1/firms/altapartners.com/portfolio
GET /v1/firms/altapartners.com/coinvestors
GET /v1/firms/altapartners.com/news